Home›Companies›Biotech & Pharma›Allevion Therapeutics

Allevion Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 26, 2024·Suggest an edit

About Allevion Therapeutics

Allevion Therapeutics is a private company based in Irvine, California. It has reported $2,475,000 raised in two offerings on Form D since July 2021.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 12, 2024Mar 26, 2024$1,475,000fully sold7$210KEquityRule 506(b)Form D ↗
Jun 29, 2021Jul 14, 2021$1,000,000fully sold1$1.0MEquityRule 506(b)Form D ↗
Total, two offerings$2,475,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Allevion Therapeutics's Form D filed Mar 26, 2024.

RT
Roy Tanaka
Director
DD
Dan Dearen
Director
SM
Shinya Miike
Director
NH
Neal Hermanowicz
Executive officer
JW
Jack Wang
Director
MR
PS
Pintoo Shah
Executive officer
RW
SM
Shahram Moaddeb
Executive officer, director and promoter

Sources

  1. SECAllevion Therapeutics, Inc. filing history